Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Deliliga, A., Chatzinikolaou F., Koutsoukis D., Chrysovergis I., & Voultsos P. (2019).  Cardiopulmonary resuscitation (CPR) complications encountered in forensic autopsy cases.. BMC Emerg Med. 19(1), 23.
Pagourelias, E. D., Koumaras C., Kakafika A. I., Tziomalos K., Zorou P. G., Athyros V. G., et al. (2009).  Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?. Angiology. 60(1), 74-81.
Kadoglou, N. P. E., Iliadis F., Angelopoulou N., Sailer N., Fotiadis G., Voliotis K., et al. (2009).  Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes.. J Diabetes Complications. 23(3), 160-6.
Zarogoulidis, P., Tsakiridis K., Kioumis I., & Zarogoulidis K. (2014).  Cardiothoracic diseases: basic treatment.. J Thorac Dis. 6 Suppl 1, S1.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2011).  Cardiovascular benefits of bariatric surgery in morbidly obese patients.. Obes Rev. 12(7), 515-24.
Kostopoulou, E., Bosdou J. K., Anagnostis P., Stevenson J. C., & Goulis D. G. (2020).  Cardiovascular complications in patients with Turner's syndrome.. Curr Pharm Des.
Sarafidis, P. A., & Bakris G. L. (2015).  Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes.. Nat Rev Nephrol. 11(2), 70-2.
Papagianni, M., & Tziomalos K. (2015).  Cardiovascular effects of dipeptidyl peptidase-4 inhibitors.. Hippokratia. 19(3), 195-9.
Chang, Y-J., Chang S-L., Chong E., Suenari K., & Michalopoulos A. (2017).  Cardiovascular Emergencies.. Biomed Res Int. 2017, 7210261.
Karamitsos, T. D., & Neubauer S. (2011).  Cardiovascular magnetic resonance: a powerful diagnostic and prognostic tool in modern cardiology.. Prog Cardiovasc Dis. 54(3), 179-80.
Repanas, T. I., Papanastasiou C. A., Efthimiadis G. K., Fragkakis N., Sachpekidis V., Klein R. Michael, et al. (2020).  Cardiovascular magnetic resonance as a complementary method to transthoracic echocardiography for aortic valve area estimation in patients with aortic stenosis: A systematic review and meta-analysis.. Hellenic J Cardiol.
Ntusi, N. A. B., Francis J. M., Gumedze F., Karvounis H., Matthews P. M., Wordsworth P. B., et al. (2019).  Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients.. Hellenic J Cardiol. 60(1), 28-35.
Mavrogeni, S., Markousis-Mavrogenis G., Koutsogeorgopoulou L., Dimitroulas T., Bratis K., Kitas G. D., et al. (2017).  Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases.. Int J Cardiol. 236, 151-156.
Karamitsos, T. D., & Neubauer S. (2011).  Cardiovascular magnetic resonance in heart failure.. Curr Cardiol Rep. 13(3), 210-9.
Athyros, V. G., Tziomalos K., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2015).  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.. World J Gastroenterol. 21(22), 6820-34.
Triantafyllou, A., & Douma S. (2019).  Cardiovascular risk assessment in elderly individuals without overt CVD disease. Could traditional risk factors fit in all ages?. J Clin Hypertens (Greenwich). 21(8), 1153-1154.
Chimonas, T., Athyros V. G., Ganotakis E., Nicolaou V., Panagiotakos D. B., Mikhailidis D. P., et al. (2010).  Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome.. Angiology. 61(1), 49-57.
Gazzaruso, C., Gola M., Karamouzis I., Giubbini R., & Giustina A. (2014).  Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update.. J Clin Endocrinol Metab. 99(1), 18-29.
Tziomalos, K., Athyros V. G., & Karagiannis A. (2015).  Cardiovascular Risk in Middle East Populations: A Call to Action.. Angiology. 66(9), 801-2.
Gkaliagkousi, E., Gavriilaki E., Aslanidis S., & Douma S. (2014).  Cardiovascular risk in psoriatic arthritis: should we focus on hypertension and diabetes only?. Clin Exp Rheumatol. 32(6), 995.
Zegkos, T., Kitas G., & Dimitroulas T. (2016).  Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps.. Ther Adv Musculoskelet Dis. 8(3), 86-101.
Patriki, D., & Giannopoulos A. A. (2018).  Cardiovascular risk prediction models with myocardial perfusion imaging in chronic kidney disease: ACCESSing digits or focusing on the patient?. J Nucl Cardiol.
Athyros, V. G., Katsiki N., & Karagiannis A. (2013).  Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients.. Curr Med Res Opin. 29(7), 791-2.
Karagiannis, T., Bekiari E., Boura P., & Tsapas A. (2016).  Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications. Therapeutic Advances in Drug Safety. 7(2), 36 - 38.
Karagiannis, T., Bekiari E., Boura P., & Tsapas A. (2016).  Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.. Ther Adv Drug Saf. 7(2), 36-8.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές